These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 6101524

  • 1. Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophrenia.
    Tune LE, Creese I, Depaulo JR, Slavney PR, Coyle JT, Snyder SH.
    Am J Psychiatry; 1980 Feb; 137(2):187-90. PubMed ID: 6101524
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum neuroleptic levels and clinical outcome in schizophrenic patients treated with fluphenazine decanoate.
    Brown WA, Silver MA.
    J Clin Psychopharmacol; 1985 Jun; 5(3):143-7. PubMed ID: 3998204
    [Abstract] [Full Text] [Related]

  • 7. Low serum neuroleptic levels predict relapse in schizophrenic patients.
    Brown WA, Laughren T, Chisholm E, Williams BW.
    Arch Gen Psychiatry; 1982 Sep; 39(9):998-1000. PubMed ID: 6126172
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum neuroleptic concentrations and clinical response: a radioreceptor assay investigation of acutely psychotic patients.
    Kucharski LT, Alexander P, Tune L, Coyle J.
    Psychopharmacology (Berl); 1984 Sep; 82(3):194-8. PubMed ID: 6144127
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients.
    Tune LE, Strauss ME, Lew MF, Breitlinger E, Coyle JT.
    Am J Psychiatry; 1982 Nov; 139(11):1460-2. PubMed ID: 6127957
    [Abstract] [Full Text] [Related]

  • 13. Low neuroleptic serum levels in patients receiving fluphenazine decanoate.
    Tune LE, Creese I, Coyle JT, Pearlson G, Snyder SH.
    Am J Psychiatry; 1980 Jan; 137(1):80-2. PubMed ID: 6101523
    [Abstract] [Full Text] [Related]

  • 14. The strategy and value of neuroleptic drug monitoring.
    Curry SH.
    J Clin Psychopharmacol; 1985 Oct; 5(5):263-71. PubMed ID: 2864358
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Study of the clinical utility of radioreceptor assay in outpatients with schizophrenia receiving high doses of neuroleptics.
    Gagné MA, Cormier H, Leblanc G, Lévesque D, Di Paolo T.
    Can J Psychiatry; 1993 Oct; 38(8):534-40. PubMed ID: 7902199
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relapse rate and low serum neuroleptic levels in schizophrenics treated with fluphenazine: another view.
    Boza RA, Milanes F, Starkey T, Slater V, Dominguez F.
    J Clin Psychiatry; 1988 Jun; 49(6):245. PubMed ID: 2897960
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Total and free plasma neuroleptic levels in schizophrenic patients.
    Tang SW, Glaister J, Davidson L, Toth R, Jeffries JJ, Seeman P.
    Psychiatry Res; 1984 Dec; 13(4):285-93. PubMed ID: 6596586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.